Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Oxidative Stress and Regulation of Pink1 in Zebrafish (Danio rerio)

  • Madhusmita Priyadarshini,

    Affiliation Neuroscience Center and Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland

  • Lori A. Orosco,

    Current address: Institute of Pediatric Regenerative Medicine Shriners, Hospitals for Children, Department of Medical Pathology and Laboratory Medicine, University of California Davis, Davis, California, United States of America

    Affiliation Carnegie Institution for Science, Department of Embryology, Baltimore, Maryland, United States of America

  • Pertti J. Panula

    Affiliation Neuroscience Center and Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland

Oxidative Stress and Regulation of Pink1 in Zebrafish (Danio rerio)

  • Madhusmita Priyadarshini, 
  • Lori A. Orosco, 
  • Pertti J. Panula


Oxidative stress-mediated neuronal dysfunction is characteristic of several neurodegenerative disorders, including Parkinson’s disease (PD). The enzyme tyrosine hydroxylase (TH) catalyzes the formation of L-DOPA, the rate-limiting step in the biosynthesis of dopamine. A lack of dopamine in the striatum is the most characteristic feature of PD, and the cause of the most dominant symptoms. Loss of function mutations in the PTEN-induced putative kinase (PINK1) gene cause autosomal recessive PD. This study explored the basic mechanisms underlying the involvement of pink1 in oxidative stress-mediated PD pathology using zebrafish as a tool. We generated a transgenic line, Tg(pink1:EGFP), and used it to study the effect of oxidative stress (exposure to H2O2) on pink1 expression. GFP expression was enhanced throughout the brain of zebrafish larvae subjected to oxidative stress. In addition to a widespread increase in pink1 mRNA expression, mild oxidative stress induced a clear decline in tyrosine hydroxylase 2 (th2), but not tyrosine hydroxylase 1 (th1) expression, in the brain of wild-type larvae. The drug L-Glutathione Reduced (LGR) has been associated with anti-oxidative and possible neuroprotective properties. Administration of LGR normalized the increased fluorescence intensity indicating pink1 transgene expression and endogenous pink1 mRNA expression in larvae subjected to oxidative stress by H2O2. In the pink1 morpholino oliogonucleotide-injected larvae, the reduction in the expression of th1 and th2 was partially rescued by LGR. The pink1 gene is a sensitive marker of oxidative stress in zebrafish, and LGR effectively normalizes the consequences of mild oxidative stress, suggesting that the neuroprotective effects of pink1 and LGR may be significant and useful in drug development.


Parkinson’s disease (PD), a common neurodegenerative disorder, is characterized by the degeneration of nigrostriatal dopamine (DA) neurons, a reduction in striatal DA levels and a decreased DA biosynthetic capacity [1]. Oxidative stress has been implicated as a factor mediating the initiation and progression of many neurodegenerative diseases, including PD. Monogenic variants have been found to be responsible for nearly 10% of the cases in the familial form of PD [2]. Identification of the familial genes responsible for PD has revealed novel proteins and pathways that are likely to be relevant in the pathogenesis of the disease. Current evidence suggests that mitochondrial insufficiency and oxidative stress together act as central players in the pathogenesis of both sporadic and genetic forms of the disease [3-6].

One of the familial genes, PINK1 (PTEN-induced putative kinase 1), is responsible for PARK6-associated autosomal recessive PD (ARPD) [7]. It is the second most common gene after parkin to be responsible for the early onset form of the disease, and shows considerable variation across different ethnic groups [8]. PINK1 has been reported to show ubiquitous expression, but higher expression has been found in the brain, myocardium of the heart and testes [9,10]. Given its subcellular localization in the mitochondria and also the cytosol, it is not surprising that PINK1 plays a role in the normal biology of mitochondria, including fission and fusion mechanisms [11]. PINK1 is essential for proper mitochondrial function and is neuroprotective against intrinsic and extrinsic physiological cellular stress. The loss of PINK1 in mice is associated with reduced activities of complex I, II, and aconitase, which are highly sensitive to oxidative stress [12]. Our previous study on the zebrafish model of PINK1 dysfunction identified HIF signaling as one of several significant pathways to be affected [13]. This reinforced the hypothesis that oxidative stress and/or hypoxic stress as a consequence of the loss of PINK1 may lead to PD. It is known that glutathione in the reduced form acts as an antioxidant [14]. The drug L-Glutathione Reduced (LGR) has previously been used to rescue some of the defects caused by PINK1 deficiency [13], but no comprehensive studies using this model have been carried out. Increased oxidative stress is the primary mechanism by which environmental toxins have been associated as potential risk factors for PD [15]. Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the biosynthesis of dopamine and other catecholamines. Differences have been noted in the concentration and availability of this enzyme and its cofactors in disease states such as PD [1]. In PINK1-deficient larval zebrafish, tyrosine hydroxylase 1 and 2 (th1 and th2) are both significantly reduced [16].

Taking into account the various genetic tools available to genetically manipulate the zebrafish genome, we sought to identify and characterize the zebrafish PINK1 promoter locus to drive GFP expression using the Tol2 transposition method. The Tol2 transposon vector has a potential to carry larger inserts without reducing its transpositional activity, allowing for highly effective stable integration of exogenous DNA [17]. How different organisms handle oxidative stress in vivo is poorly understood. Therefore, by using the wild-type strain, larvae with pink1 deficiency produced by morpholino oligonucleotides, and the PINK1 promoter-driven transgenic fish line, we studied the effect of oxidative stress and evaluated the therapeutic potential of LGR in this model.

Materials and Methods

Fish maintenance

Zebrafish of the Turku line, used for more than a decade in experimental work, were used in these experiments because of their high reproductive capacity and fertility [16,18,19]. Transgenic PINK1 fish were created from this strain of fish. They were staged in hours post-fertilization (hpf) or days post-fertilization (dpf) based on [20]. The characterized antisense morpholino oligonucleotide (MO) from our previously published paper was used to inhibit PINK1 function [16]. The ethical permits and approval for the experiments were obtained from the Regional Government of Southern Finland, numbered ESAVI/3623/04.10.03/2012.

Tol2 transgenic fish design

Transgenic fish were created by the Tol2 method using a gateway cloning kit (Invitrogen, Carlsbad, USA). The primers used for amplifying the gene promoter were as follows: GGGGACAAGTTTGTACAAAAAAGCAGGCTAATGATGCATCTCAGTCATTC as the forward primer and GGGGACCACTTTGTACAAGAAAGCTGGGTCTTTACTGACATTTTGAGCCAA as the reverse primer. The primers were designed to add attB sites to the final product to allow for insertion into the donor vector pDONR221 when performing the first reaction step of the gateway cloning. The clone was PCR verified and the insert was transformed into the destination vector pXIG-cfos-GW [21], and the sequence was then verified. The transposase mRNA was made from the pCS-TP vector as described earlier [22,23]. Both the transposase mRNA and the donor plasmid were injected into the zebrafish embryos at the one-cell stage at 25 ng/μl each. We outcrossed the founder fish (F0) with wild-type fish and collected the progeny embryos (F1). GFP expression was visualized in the injected embryos, and three founder fish lines differing in the levels of GFP expression were identified. One of these founder lines was chosen based on the maximum GFP expression pattern and named Tg(pink1:EGFP). These fish were crossed to produce stable line embryos (F2), which were grown until adults, and experiments were carried out on the F2 generation onwards.

Immunohistochemistry (IHC)

Embryos of different stages from 3 days post-fertilization (dpf) until 8 dpf were fixed with 4% PFA overnight at +4 °C. The samples were washed with PBST 3 x 30 min at RT followed by a pre-incubation with PBST, 1% DMSO, and 4% normal goat serum (NGS) for 4 hours to o/n at RT. The anti-GFP, chicken IgY fraction (Invitrogen, Carlsbad, USA) was used to stain the transgenic fish at 1:500 dilution o/n in PBST with 2% NGS at +4 °C. The other antibodies used were those against tyrosine hydroxylase (TH), PINK1 and 5-hydroxy tryptophan (5-HT) at 1:1000 dilution (Kaslin and Panula, 2001,Sallinen et al., 2010,Kaslin and Panula, 2001). The samples were handled and treated as has previously been described [16].

For brain sections, adult brain samples were dissected and fixed in 4% PFA overnight, followed by 20% sucrose for the following incubation overnight at +4 °C. Cryosections were made by embedding the brain samples in the embedding matrix, maintaining the section thickness at 25 µm for all the samples.

Immunofluorescence samples were mounted with 80% glycerol and examined under a Leica TCS SP2 AOBS confocal microscope, using an argon laser (488 nm) and green diode laser (561 nm). The emission wavelength was set to 500–550 nm for Alexa 488 and 600–750 nm for Alexa 561, as described earlier [24]. Stacks of images were taken at 1.2-µm intervals, collected by sequential scanning. Frame averaging was carried out, and the maximum intensity projection algorithm was used to produce the final images with Leica Confocal Software. In each individual experiment, samples were scanned using the same parameters. Pictures were then compiled in Corel Draw 12 software (Corel Corporation, Ottawa, Canada). 3D volume rendering and the fluorescence intensity measurement was performed using the Imaris MeasurementPro module in Imaris 6.0 software (Bitplane AG, Zurich, Switzerland). Each of the IHC experiments included at least 12 individuals per group for imaging, and each set of experiments was repeated at least three times.

In situ hybridization (ISH)

The larval fish at 3 dpf, 7 dpf and 8 dpf were fixed with 4% PFA o/n at +4 °C. The brains were dissected from 7- and 8-dpf-old larvae and stored in 100% methanol until further use. Digoxigenin (DIG)-labeled probes were made for th1, th2, dat, and pink1 as described earlier [13]. The ISH protocol from Thisse et al. was used to perform the experiments [25]. Image analysis was conducted as described earlier [16,26,27].

Chemicals and drug treatment

Hydrogen peroxide (H2O2) (Merck, NJ, USA) was used at a concentration of 5 µM for 20 min to create oxidative stress similar to the environment for the studies on wild-type and transgenic fish. L-Glutathione Reduced (LGR) (G4251) (Sigma-Aldrich, St. Louis, MO, USA) was used at a concentration of 100 μM for 24 h after H2O2 treatment. The dose and duration of LGR treatment had been tested and previously used on the morphants [13]. The samples were washed with E3 fish medium followed by the application of LGR for 24 hours. They were then processed for further experimentation.


RNA samples were isolated from pooled embryos from untreated and H2O2-treated wild-type fish (30 embryos/sample) with an RNAEasy minikit (Qiagen) at 3 dpf. RNA was reverse transcribed to produce cDNA using superscript reverse transcriptase-III (Invitrogen) primed with oligo (dT) primers according to the manufacturer’s instructions. Similar instrumentation and procedures for real-time PCR were followed as described earlier [13].


Characterization of PINK1 transgene expression

The zebrafish PINK1 gene is located on chromosome 23 and shares 53% and 54% sequence identity with humans and mice, respectively, with a highly conserved sequence in the functional domains. The pink1 transcripts can be detected as early as 3 hpf and expression persists throughout adulthood [16]. Several promoter constructs were produced and tested to identify at least the minimal promoter activity to drive PINK1 expression. A functional promoter construct included a 2-kilobase fragment of the 5'-flanking region from the translational start site and contained transcriptional regulatory sequences that were able to drive strong and ubiquitous GFP expression after injection into a single-cell embryo. This was created by the Tol2 transposition vector system [21] (Figure 1 A). In stable Tg(pink1:EGFP) transgenic lines, GFP was expressed in distinct regions from embryo to adulthood. The highest expressing regions were visualized in the brain, heart, liver and muscle by IHC on whole-mount fish embryos with GFP antibodies (Figure 1B-C). From the dorsal side of the intact brain, it was apparent that PINK1 GFP expression marked the mid-hindbrain boundary (MHB) (Figure 1D). Although low-level transgene expression showed a ubiquitous expression pattern, there were areas of higher expression in the brain. Analysis of the brain regions showed the highest GFP expression in the telencephalon (Tel), optic tectum (TeO), thalamus (T), and in discrete regions of the hypothalamus and rhombencephalon (rho) (Figure 1E-F). The GFP expression often colocalized with the PINK1-ir, suggesting that expression of the transgene follows the endogenous pink1 expression pattern (Figure 2). The overlap was consistent with our previously published study on PINK1 [16]. The expression pattern in the brain at 7 dpf was compared with the pattern of TH immunoreactivity (ir) and 5-HT-ir (Figure 1). Although overlap in some of the cells was seen with TH and 5-HT immunoreactive regions, it was not apparent in all the cells (Figure S1 A–F). Transgene expression in the larval and adult brain sections was analyzed and a schematic representation of the highly apparent PINK1 transgene expression in zebrafish brain was prepared, as shown in Figure S2 A.

Figure 1. The PINK1 promoter construct and expression pattern in zebrafish larva of the Tg(pink1:EGFP) line.

A. Construction of the PINK1 promoter DNA fragment comprising the sequence -2 kb upstream of the 5’ end of the pink1 gene and including the ATG start site. This is inserted in the cloning site in the Tol2 transposon vector pCS-cfosGFP, which contains a small intronic sequence and a GFP expression cassette having minimal cfos activity [21]. B-F. Confocal z-stack images of the whole-mount Tg(pink1:EGFP) larval stages.

B. GFP expression as observed in peripheral tissues at different stages of development by GFP IHC. In a lateral view of 4 dpf whole mount larvae, expression was observed in the heart (H) and liver (L); anterior to the left.

C. Expression in the muscle of the 4-dpf larvae in a lateral view (M); anterior to the left.

D. The whole mount GFP expression at 5 dpf; dorsal views, anterior to the top, showing pronounced immunoreactive cells in brain regions such as the telencephalon (Tel), mid-hindbrain boundary (MHB) and rhombencephalon (rho).

E- F. Dorsal and ventral views of the brain of 7-dpf Tg(pink1:EGFP) fish; anterior to the right.

E. In the ventral view, the strongest GFP expression is seen in the telencephalon (Tel), anterior part of optic tectum (TeO), thalamus (T), and the lateral rhombencephalon (rho). F. The dorsal view shows the prominent expression in the mid-hindbrain boundary (MHB) along with Tel and rho.

Scale bar represents 100μm. GFP – Green fluorescent protein, PINK1 – PTEN-induced putative kinase 1.

Figure 2. A-C. The PINK1-ir colocalizes with the GFP expression pattern in the brain of 7-dpf fish from the transgenic line in most parts of the brain. Colocalization was visualized in the telencephalon (arrow), the thalamic region (*), and the rhombencephalon (arrowhead).

D-L. Representative higher magnification images from adult brain sections (25 µm) for PINK1-ir and GFP-ir. D-F represents the telencephalic region in the saggital plane. G-I represents the thalamic region, and J-L represents the rhombencephalic region from the coronal plane. GFP – Green fluorescent protein, PINK1 – PTEN-induced putative kinase 1, ir – Immunoreactivity.

Oxidative stress

To investigate the role of stress in PINK1 regulation, we used the transgenic line as well as wild-type larvae. The transgenic larvae and the wild-type larvae were subjected to a mild heat shock or treated with 5 μM H2O2. Changes in transgene expression were observed by performing IHC with the GFP antibody, and in wild-type fish, gene expression was detected by ISH and transcript levels were measured by q-RT-PCR. To determine whether Tg(pink1:EGFP) reflects pink1 responses to oxidative stress, we subjected the transgenic larvae to a very low concentration of H2O2 for 20 min and fixed the larvae to perform IHC with GFP antibodies. The PINK1 transgenic larvae showed an increase in GFP-expressing cells in the whole brain compared to the control fish without treatment (Figure 3 A–C). This effect was reduced in the presence of the drug L-Glutathione Reduced (LGR). The change in expression levels of the transgene was pronounced. We therefore created a 3D image using the ImarisMeasurementPro module in Imaris software (Bitplane) and visualized the volume of cells expressing the transgene in different planes. The apparent increase in transgene expression in certain regions of the brain could be easily visualized by the 3D representation. The volume of GFP-expressing cells in the H2O2-treated group was considerably larger than that of control brain and LGR-treated brain samples from the Tg(pink1:EGFP) line (Figure 3 D–F). Increased expression was evident in the telencephalon and midbrain, extending to the hindbrain. The mean fluorescence intensities of the groups were measured and mapped in a graphical manner, as shown in Figure 3 G. The Tg(pink1:EGFP) fish were subjected to heat shock, but no effect on the expression levels of the transgene was observed (data not shown). We then analyzed the effect of H2O2 treatment on TH-ir in dopaminergic neuron groups and found no differences between the control and H2O2-treated fish (Figure 3 H-I). However, the monoclonal antibody used only identifies the TH1 protein and not the TH2 protein [26]. No significant differences were detected in dat (dopamine transporter) expression as observed by q-RT-PCR and ISH (Figure S3).

Figure 3. The effect of H2O2 on GFP and TH1 expression in Tg(pink1:EGFP) larval fish.

A-C. GFP-ir at 7 dpf in the zebrafish larvae. GFP-ir increases in the H2O2-treated fish (B) as compared to the control fish (A). The effect is rescued in the LGR treated fish (C).

D. Mean fluorescence intensity values of the WT, H2O2-treated group and the H2O2+LGR treated group. A significant change in the H2O2-treated group was observed (p < 0.01).

E-G. A three-dimensional image to perform volume rendering was constructed using the Imaris MeasurementPro module in Imaris software for the above-mentioned fish at a similar threshold intensity. The changes indicated as the changed total volume of the representative images for control (E), H2O2 (F) and LGR-treated fish (G). Scale bar represents 80 μm.

H-J. TH-ir is unchanged among the control (H), H2O2-treated (I) and H2O2 together with LGR (J) groups of larval fish. No change in the pretectal (7) and preoptic, thalamic or pre-tectal nucleus (5,6,11) cell populations was seen. Other visible groups in the olfactory bulb and ventral telencephalic nuclei (1,2), periventricular hypothalamus and posterior tuberculum (13), and the locus coeruleus (14) also displayed no change in TH-ir.

Scale bar represents 100 μm. A-C and H-J. H2O2 – Hydrogen Peroxide, GFP – Green fluorescent protein, ir – immunoreactivity, LGR – L-glutathione reduced, PINK1 – PTEN-induced putative kinase 1, TH – tyrosine hydroxylase.

To examine whether H2O2 treatment affected th2 expression, we studied the transcript levels of th2, pink1, and th1 by q-RT-PCR in wild-type larvae at 3 dpf (Figure 4 A–C). A decrease in th2 and an increase in pink1 transcripts were detected, while no change occurred in th1 levels. These effects were also rescued by LGR administration, as revealed by q-RT-PCR. The Turku strain wild-type larvae were subjected to H2O2 at 7 dpf, and the effect of LGR on th2 and pink1 expression was studied at 8 dpf. In situ hybridization was performed at 7 dpf, because changes in th2 levels could be monitored effectively in all the individual cell groups expressing th2. In agreement with the q-RT-PCR results, the signal intensities of th2 were reduced in the H2O2-treated groups, and were rescued by LGR (Figure 4 D–F).

Figure 4. In-situ hybridization and q-RT-PCR at 3dpf in wild type fish following treatment with H2O2 and H2O2+LGR.

A. The th2 transcript levels significantly decreased in the H2O2 treated samples, verified by q-RT-PCR.

B. The pink1 transcript levels increased significantly in the H2O2 treated as compared to wild type samples.

C. No significant change in the th1 transcript levels was detected between the groups. Only a declining trend was observed.

Unpaired t-test (* p-value < 0.05, ** p-value< 0.01).

D-F. The expression of th2 mRNA is reduced in group 10b of the 7-dpf H2O2-treated fish as compared with untreated control fish. In the LGR-treated groups at 8 dpf, the decrease in th2 mRNA expression was prevented. The th2-expressing neuron groups 3b, 8b, 9b, 10b are identified according to [26].

Scale bar represents 100 μM. th1 – tyrosine hydroxylase1, th2 – tyrosine hydroxylase 2, pink1 – PTEN-induced putative kinase 1.

Effect of the drug LGR on pink1 morphants

The loss of dopaminergic neurons is a characteristic feature of PD. In zebrafish, the dopaminergic system has been visualized by TH immunoreactivity. Following the identification of the second th gene, we have focused on the differential expression of th1 and th2 in the current study. Our previous study on pink1 revealed that LGR was an effective drug that could normalize erythropoiesis in pink1-deficient fish [13]. Here, we utilized the same drug regime to treat the pink1 morphants and to study the effects on th1 and th2 expression, which was decreased in the morphants, as reported earlier at 3 dpf [16].

In our previous study, using the same pink1 MO, we demonstrated that th1 expression declined in the morphants in the cell group complex of 5,6,11, which represents the preoptic, thalamic and pre-tectal nucleus in the diencephalon [28]. This cluster of neurons has also been named as the ventral diencephalic group (vDC) [29]. In the current study, we subjected the wild-type fish to pink1 MO, standard MO, and co-injected a group with pink1 MO and pink1 mRNA, and examined the effect of LGR on the expression of th1 and th2 (Figure 5). The loss of group 5,6,11, representing th1 neurons in pink1 morphants, was rescued by pink1 mRNA, as has been observed by ISH (Figure 5 A–C). The effect was verified by q-RT-PCR (Figure 5 D). The effect of LGR on morphants slightly increased th1 expression in the pink1 morphants (Figure 5 E–G). LGR treatment could also rescue the th1 amacrine cells, which lost visible expression, in the retina of the morphants and partially in the pre-tectal region (Figure 5 B and F). In the rescue group (Figure 5 F), the additive effect of pink1 mRNA and LGR enhanced th1 expression to a larger magnitude than that seen in the standard MO group, as was quantified by q-RT-PCR (Figures 5 H).

Figure 5. Expression levels of th1 and th2 mRNA at 3 dpf in pink1 morphants untreated and treated with LGR.

A-C. Altered th1 expression in the untreated std ctrl MO, pink1MO, and pink1MO+mRNA groups. A decrease in th1 expression in the population 5,6,11 (*) in morphants (B) was observed as compared to the ctrl MO group (A). The expression could be rescued by pink1 mRNA co-injection (C).

D. Representative quantitative graph for the untreated group.

E-G. The expression of th1 ISH in LGR-treated groups. The drug LGR rescued the reduced th1 cells in the eyes and also group 5,6,11 of the morphants (E) as compared to the ctrl MO group (D). The expression is enhanced in the rescue group with the combined effect of LGR and pink1 mRNA (F).

H. Graphical representation of the transcript levels for th1 in the LGR-treated group. A significant change in the pink1 mRNA co-injected group.

I-K. The expression of th2 ISH in the untreated std MO, pink1MO, and pink1MO+mRNA groups. A loss of th2 was observed in group 10b in the pink1 morphants (H) as compared to ctrl MO (G). The pink1 mRNA rescued th2 expression in group 10b (I).

L. The representative th2 transcript levels determined by q-RT-PCR for the untreated group.

M-O. The expression of th2 ISH in LGR treated groups. LGR-treated pink1 MO shows a slight increase in the th2 10b group (K) as compared to ctrl MO (J). The pink1 mRNA along with LGR completely rescues the loss of th2 in the 10b cell group (L).

P. Representative q-RT-PCR results for the th2 LGR-treated group. A significant change in the pink1 mRNA co-injected group together with LGR significantly increased the th2 transcript levels.

Figures D and L present confirmation of th1 and th2 transcripts downregulation in the pink1 morphants. Figures H and P present the additive rescue effect of LGR together with pink1 mRNA on the morphants.

The Bonferroni Hochberg multiple comparison statistical test was applied for the q-RT-PCR results (* p < 0.05, ** p < 0.01, *** p < 0.001). ISH – in-situ hybridization, LGR – L-glutathione reduced, MO – morpholino oligonucleotides, pink1 – PTEN-induced putative kinase 1, q-RT-PCR – quantitative real-time PCR, th1 – tyrosine hydroxylase1, th2 – tyrosine hydroxylase 2.

Scale bar represents 100 μm.

We analyzed th2 expression patterns in the standard MO, pink1 MO and pink1 MO + pink1 mRNA co-injected samples without treatment (Figure 5 I–K) and with LGR treatment (Figure 5 M–O). LGR improved th2 expression in the pink1 morphants in the dopaminergic cell group 10b (as defined in [26]), and the effect of the drug with pink1 mRNA was stronger than that of pink1 mRNA alone (Figures 5 K, O). The loss of th2 expression has been verified in the morphants by q-RT-PCR (Figure 5 L). The drug LGR was quite effective for th2 cell group enrichment, as can also be seen from the q-RT-PCR results (Figure 5 P).


The goal of this study was to develop and validate a transgenic model that will help in the interpretation of the precise function of the PINK1 in vivo, and to study the effects of oxidative stress and PINK1 dysfunction on th genes. Our data objectively demonstrate that oxidative stress significantly downregulates th2 in distinct neuronal cell populations and upregulates pink1 in larval zebrafish. Both effects were normalized by treatment with L-Glutathione Reduced. Reduced glutathione could also rescue, along with pink1 mRNA, both th1 and th2 expressing cell populations, which were lost in pink1 morphants.

The existing experimental evidence strongly suggests that PINK1 protects neurons against oxidative stress and also neurotoxins. In neuroblastoma cells treated with toxins such as staurosporine and MG132, PINK1 overexpression suppresses toxin-induced damage [30,31]. The development of the transgenic line for PINK1 provided us with a tool to visualize and characterize the dynamic changes in its expression in live zebrafish. The Tg(pink1:EGFP) line provided strong transgene expression that was integrated into the germline and sustained over several generations. Even though PINK1 is ubiquitously expressed, transgene expression was apparently higher in some regions than others. It has not been ruled out that the patterns we see could be attributed to the lack of some regulatory elements in the 2 kilobase genomic segment used in this study. This needs to be taken into account in future use of this fish line. This phenomenon with ubiquitous promoters for genes such as ubi and β-actin has previously shown that these promoters, with strong expression during development, gradually become silenced and restricted to certain cell groups, and are not expressed in others [32,33]. This is either due to random integration into the genome or due to special cell type-specific functions. Analysis of the detailed expression pattern of PINK1 in zebrafish has been lacking. In the mouse and rat, PINK1 mRNA is expressed unevenly in neurons of the cortex, striatum, thalamus, brainstem, and cerebellum [34]. In humans, PINK1 expression is highest in the hippocampus, substantia nigra and cerebellar Purkinje cells [35]. We have reported the expression in different brain regions with PINK1 antibody [16], and in the transgenic fish we were able to visualize the expression pattern throughout their development and confirm the ubiquitous expression pattern in the vast majority of cell types by GFP IHC. Apparently higher expression was observed in the telencephalon, anterior part of optic tectum, thalamus, rhombencephalon, and mid-hindbrain boundary in the larval and adult brain sections. The expression pattern of the transgene was very similar to the pink1 fish pattern, which indicated that the transgenic fish recapitulate endogenous gene expression. The pink1 promoter is not expressed at same level in all cell types. These effects are anticipated for these randomly integrated transgene constructs [32].

Effect of H2O2 on the transgenic fish line

Based on previous studies in different cell lines, PINK1 has neuroprotective activity, most likely by antagonizing mitochondrial dysfunction caused by oxidative stress and neurotoxins [30]. PINK1 overexpression in the neuroblastoma cell line SHSY5Y could rescue cell death caused by neurotoxins [31]. Postmortem investigations of PD patients and findings from studies using the selective nigral toxin MPTP have revealed increased iron levels, decreased levels of reduced glutathione (GSH), and impaired mitochondrial function [15], which supports the hypothesis that oxidative stress contributes to nigral cell degeneration in PD. Administration of H2O2 leads to similar damage in different strains of zebrafish [36]. The free radical generator H2O2 has been used in the oxidative stress model of PD in the SHSY5Y cell line as an in vitro model [37]. Pink1 overexpression protects cells against oxidative stress, which is achieved by TRAP1 phosphorylation [38]. The H2O2 treatment concentration in this study was selected based on previous studies, which have reported that doses below 150 μM are safe for zebrafish embryos and cause no abnormalities [39]. Therefore, we decided to use a very low concentration (5 μM) of H2O2 for treatment that would have no deleterious effects on the normal fish phenotype or behavior, but could possibly still trigger a physiological stress response. This concentration was indeed sufficient to alter the expression pattern of pink1 in the transgenic line, and pink1 and th2 in the wild-type fish, but it was not enough to significantly disrupt the transcript levels of th1. In summary, th2 together with pink1 was more sensitive to H2O2 than th1.

Differential regulation of the catecholaminergic systems

We could see that TH-ir, which mostly detects th1 [26], did not change considerably in H2O2-treated samples, while th2 mRNA levels declined. This result was also confirmed by q-RT-PCR, in which the th2 gene was significantly downregulated, while the th1 transcript did not show any significant changes. The two th genes have been known to show differential regulation in teleosts [40]. Additional studies have been performed using different markers for the dopaminergic system, which have revealed that th2 neurons are dopamine-synthesizing cells, in addition to th1 cells [29,41]. Dopamine cells are very vulnerable to slight changes in oxygen, because TH is the rate-limiting enzyme in catecholamine synthesis and requires oxygen as its cofactor. Therefore, low levels of cellular oxygen or environmental oxygen would affect the levels of both th genes. In zebrafish, th2 is known to be more vulnerable to slight changes in oxygen than th1 [42]. In this study, the applied concentration of H2O2 was quite low and did not significantly affect the th1 levels, but was sufficient to alter th2 levels. A recently published paper stated that th2 had tryptophan hydroxylase-like activity [43]. Independent verification has not been published and this question was not addressed in this study. The mechanisms of differential regulation of the two non-allelic th forms need further investigation. A mutant for th2 could be beneficial in order to understand the precise function of th2 in the brain.

In pink1 morphant larvae, the pink1 mRNA could rescue the detrimental effects caused by the knockdown. When LGR was added, in addition to the pink1 mRNA, the rescue effect was clearly enriched. LGR is a thiol antioxidant and protects cells from various cytotoxic insults, as indicated in a study conducted on rabbits [14]. Glutathione is administered in the reduced form, as it can more easily cross the cell membrane than glutathione itself [44]. It has also been shown that the level of glutathione within the cell is quite critical for the cellular redox balance [14]. This provides suitable evidence that PINK1 and glutathione might operate on the same pathways. The present study contributes to our understanding of the mechanism of PD pathogenesis in the oxidative stress-mediated pathway.


This study suggests that PINK1 activity could potentially serve as a valid target for neuroprotection in PD. The drug L-Glutathione Reduced could effectively normalize the decline in th2 and th1 expression in the pink1 morphants and it could also recover the altered levels of th2 and pink1 in the groups subjected to H2O2 in the oxidative stress model. This protective effect of glutathione on the dopaminergic system may prove significant for drug development targeted at the early phases of degenerative diseases such as PD. The zebrafish is now emerging as an alternative for modeling human disease and drug discovery [45,46]. The development of the Tg(pink1:EGFP) zebrafish has provided a useful tool for drug screening and the mechanistic analysis of oxidative damage in the central nervous system as a whole, in addition to analysis of the dopaminergic system and PD mechanisms. The Tg(pink1:EGFP) line potentially responds to subtle changes in the external environment and this makes it a valuable tool for study of environmental stressors on pink1 gene function.

Supporting Information

Figure S1.

Comparison of the GFP expression pattern with TH-ir and 5-HT-ir in Tg(pink1:EGFP) fish at 7 dpf. D-F. TH ir compared to GFP distribution in the Tg(pink1:EGFP) fish. GFP is more widely distributed than TH-ir. A ventral view of the maximum projection images for TH and GFP. The cell populations and numbering are as in [28].

G-I. The 5-HT-ir is colocalized with GFP expression in the posterior recess of the paraventricular organ (arrowhead).

5-HT – 5-hydroxy tryptophan, TH – tyrosine hydroxylase, ir – immunoreactivity, GFP – Green fluorescent protein, PVOa – paraventricular organ anterior part, PVOi – paraventricular organ intermediate part, PVOp – paraventricular organ posterior part.

Scale bar represents 100 μm.


Figure S2.

A. Schematic lateral view of pink1:egfp expressing regions in the zebrafish brain compiled from immunohistochemistry of larval and adult brain sections. The regions are marked as: Tel – telencephalon, Teo – anterior region of the optic tectum, Hy – hypothalamus, rho – rhombencephalon.

B-E. Cryosections of different regions of the adult zebrafish brain with immunoreactivity detected for TH (red), PINK1 (blue) and pink1:egfp (green). The cell populations of TH-ir are reported with numbers, and additional regions of GFP are marked with dotted lines.

Di – lateral zone of the dorsal telencephalon, ENd – endopeduncular nucleus, VOT – ventrolateral optic tract, TeO – tectum opticum, PTN – posterior tuberal nucleus, Hc – caudal zone of the periventricular hypothalamus, LCa – lobus caudalis cerebelli, ALLN – anterior lateral line nerves.

Scale bar represents 100 μm.


Figure S3.

The transcript levels of dat in WT and H2O2-treated fish. A. Larval groups measured by q-RT-PCR. No significant level of transcript alteration was visualized amongst the groups.

B. No change in expression levels between the two groups was also observed by ISH.

Scale bar represents 100 µm.



We thank Henri Koivula, BSc, Reeta Korhonen, MPh, and Susanna Norrbacka, BSc, for expert technical help and also for fish maintenance. We thank Prof. Marnie Halpern for fruitful collaboration and help with the production of the transgenic fish.

Author Contributions

Conceived and designed the experiments: PP MP. Performed the experiments: MP LAO. Analyzed the data: MP PP. Contributed reagents/materials/analysis tools: PP LAO MP. Wrote the manuscript: MP PP. Improved the manuscript: LAO.


  1. 1. Haavik J, Toska K (1998) Tyrosine hydroxylase and parkinson's disease. Mol Neurobiol 16: 285-309. doi:10.1007/BF02741387. PubMed: 9626667.
  2. 2. Singleton AB, Farrer MJ, Bonifati V (2013) The genetics of parkinson's disease: Progress and therapeutic implications. Mov Disord 28: 14-23. doi:10.1002/mds.25249. PubMed: 23389780.
  3. 3. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE (1987) MPTP, MPP+ and mitochondrial function. Life Sci 40: 721-729. doi:10.1016/0024-3205(87)90299-2. PubMed: 3100899.
  4. 4. Onyango IS (2008) Mitochondrial dysfunction and oxidative stress in parkinson’s disease. Neurochem Res 33: 589-597. doi:10.1007/s11064-007-9482-y. PubMed: 17940895.
  5. 5. Bové J, Perier C (2012) Neurotoxin-based models of parkinson's disease. Neuroscience 211: 51-76. doi:10.1016/j.neuroscience.2011.10.057. PubMed: 22108613.
  6. 6. Santos D, Cardoso SM (2012) Mitochondrial dynamics and neuronal fate in parkinson's disease. Mitochondrion 12: 428-437. doi:10.1016/j.mito.2012.05.002. PubMed: 22609323.
  7. 7. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K et al. (2004) Hereditary early-onset parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160. doi:10.1126/science.1096284. PubMed: 15087508.
  8. 8. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE (2007) Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6: 652-662. doi:10.1016/S1474-4422(07)70174-6. PubMed: 17582365.
  9. 9. Unoki M, Nakamura Y (2001) Growth-suppressive effects ofBPOZandEGR2, two genes involved in thePTENsignaling pathway. Oncogene 20: 4457-4465. doi:10.1038/sj.onc.1204608. PubMed: 11494141.
  10. 10. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B et al. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14: 3477-3492. doi:10.1093/hmg/ddi377. PubMed: 16207731.
  11. 11. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A et al. (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A 105: 7070-7075. doi:10.1073/pnas.0711845105. PubMed: 18443288.
  12. 12. Gautier CA, Kitada T, Shen J (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105: 11364-11369. doi:10.1073/pnas.0802076105. PubMed: 18687901.
  13. 13. Priyadarshini M, Tuimala J, Chen YC, Panula P (2013) A zebrafish model of PINK1 deficiency reveals key pathway dysfunction including HIF signaling. Neurobiol Dis 54: 127-138. doi:10.1016/j.nbd.2013.02.002. PubMed: 23454196.
  14. 14. Atakisi O, Erdogan HM, Atakisi E, Citil M, Kanici A et al. (2010) Effects of reduced glutathione on nitric oxide level, total antioxidant and oxidant capacity and adenosine deaminase activity. Eur Rev Med Pharmacol Sci 14: 19-23. PubMed: 20184085.
  15. 15. Jenner P (1989) Clues to the mechanism underlying dopamine cell death in parkinson's disease. J Neurol Neurosurg Psychiatry, Suppl: 22-28 PubMed: 2666576.
  16. 16. Sallinen V, Kolehmainen J, Priyadarshini M, Toleikyte G, Chen YC et al. (2010) Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol Dis 40: 93-101. doi:10.1016/j.nbd.2010.06.001. PubMed: 20600915.
  17. 17. Iida A, Tachibana A, Hamada S, Hori H, Koga A (2004) Low transposition frequency of the medaka fish Tol2 element may be due to extranuclear localization of its transposase. Genes Genet Syst 79: 119-124. doi:10.1266/ggs.79.119. PubMed: 15215677.
  18. 18. Eriksson KS, Peitsaro N, Karlstedt K, Kaslin J, Panula P (1998) Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems. Eur J Neurosci 10: 3799-3812. doi:10.1046/j.1460-9568.1998.00394.x. PubMed: 9875358.
  19. 19. Kaslin J, Panula P (2001) Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (danio rerio). J Comp Neurol 440: 342-377. doi:10.1002/cne.1390. PubMed: 11745628.
  20. 20. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310. doi:10.1002/aja.1002030302. PubMed: 8589427.
  21. 21. Fisher S, Grice EA, Vinton RM, Bessling SL, Urasaki A et al. (2006) Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat Protoc 1: 1297-1305. doi:10.1038/nprot.2006.230. PubMed: 17406414.
  22. 22. Kawakami K (2007) Tol2: A versatile gene transfer vector in vertebrates. Genome Biol 8 Suppl 1: S7. doi:10.1186/gb-2007-8-1-r7. PubMed: 18047699.
  23. 23. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME et al. (2007) The Tol2kit: A multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236: 3088-3099. doi:10.1002/dvdy.21343. PubMed: 17937395.
  24. 24. Kaslin J, Nystedt JM, Ostergård M, Peitsaro N, Panula P (2004) The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 24: 2678-2689. doi:10.1523/JNEUROSCI.4908-03.2004. PubMed: 15028760.
  25. 25. Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3: 59-69. doi:10.1038/nnano.2008.25. PubMed: 18193022.
  26. 26. Chen YC, Priyadarshini M, Panula P (2009) Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish. Histochem Cell Biol 132: 375-381. doi:10.1007/s00418-009-0619-8. PubMed: 19603179.
  27. 27. Priyadarshini M, Tuimala J, Chen YC, Panula P (2013) A zebrafish model of PINK1 deficiency reveals key pathway dysfunction including HIF signaling. Neurobiol Dis 54: 127-138. doi:10.1016/j.nbd.2013.02.002. PubMed: 23454196.
  28. 28. Sallinen V, Sundvik M, Reenilä I, Peitsaro N, Khrustalyov D et al. (2009) Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 109: 403-415. doi:10.1111/j.1471-4159.2009.05986.x. PubMed: 19222706.
  29. 29. Filippi A, Mahler J, Schweitzer J, Driever W (2010) Expression of the paralogous tyrosine hydroxylase encoding genes th1 and th2 reveals the full complement of dopaminergic and noradrenergic neurons in zebrafish larval and juvenile brain. J Comp Neurol 518: 423-438. doi:10.1002/cne.22213. PubMed: 20017209.
  30. 30. Mills RD, Sim CH, Mok SS, Mulhern TD, Culvenor JG et al. (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 105: 18-33. doi:10.1111/j.1471-4159.2008.05249.x. PubMed: 18221368.
  31. 31. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by parkinson disease-related mutations. J Biol Chem 7: 280. PubMed: 16079129.
  32. 32. Mosimann C, Kaufman CK, Li P, Pugach EK, Tamplin OJ et al. (2011) Ubiquitous transgene expression and cre-based recombination driven by the ubiquitin promoter in zebrafish. Development 138: 169-177. doi:10.1242/dev.059345. PubMed: 21138979.
  33. 33. Yoshinari N, Ando K, Kudo A, Kinoshita M, Kawakami A (2012) Colored medaka and zebrafish: Transgenics with ubiquitous and strong transgene expression driven by the medaka beta-actin promoter. Dev Growth Differ 54: 818-828. doi:10.1111/dgd.12013. PubMed: 23157381.
  34. 34. Taymans JM, Van den Haute C, Baekelandt V (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 98: 951-961. doi:10.1111/j.1471-4159.2006.03919.x. PubMed: 16771836.
  35. 35. Blackinton JG, Anvret A, Beilina A, Olson L, Cookson MR et al. (2007) Expression of PINK1 mRNA in human and rodent brain and in parkinson's disease. Brain Res 1184: 10-16. doi:10.1016/j.brainres.2007.09.056. PubMed: 17950257.
  36. 36. Bretaud S, MacRaild S, Ingham PW, Bandmann O (2011) The influence of the zebrafish genetic background on parkinson's disease-related aspects. Zebrafish 8: 103-108. doi:10.1089/zeb.2011.0697. PubMed: 21745139.
  37. 37. Chien WL, Lee TR, Hung SY, Kang KH, Lee MJ et al. (2011) Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of parkinson-related gene of PINK1. J Neurochem 117: 643-653. PubMed: 21366594.
  38. 38. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5: e172. doi:10.1371/journal.pbio.0050172. PubMed: 17579517.
  39. 39. Kishi S, Bayliss PE, Uchiyama J, Koshimizu E, Qi J et al. (2008) The identification of zebrafish mutants showing alterations in senescence-associated biomarkers. PLoS Genet 4: e1000152. PubMed: 18704191.
  40. 40. Candy J, Collet C (2005) Two tyrosine hydroxylase genes in teleosts. Biochim Biophys Acta 1727: 35-44. doi:10.1016/j.bbaexp.2004.11.005. PubMed: 15652156.
  41. 41. Yamamoto K, Ruuskanen JO, Wullimann MF, Vernier P (2010) Two tyrosine hydroxylase genes in vertebrates: New dopaminergic territories revealed in the zebrafish brain. Mol Cell Neurosci 43: 394-402. doi:10.1016/j.mcn.2010.01.006. PubMed: 20123022.
  42. 42. Steele SL, Ekker M, Perry SF (2011) Interactive effects of development and hypoxia on catecholamine synthesis and cardiac function in zebrafish (danio rerio). J Comp Physiol B, 181: 527–38. PubMed: 21197535.
  43. 43. Ren G, Li S, Zhong H, Lin S (2013) Zebrafish tyrosine hydroxylase 2 gene encodes tryptophan hydroxylase. J Biol Chem, 288: 22451–9. PubMed: 23754283.
  44. 44. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711-760. doi:10.1146/ PubMed: 6137189.
  45. 45. Kari G, Rodeck U, Dicker AP (2007) Zebrafish: An emerging model system for human disease and drug discovery. Clin Pharmacol Ther 82: 70-80. doi:10.1038/sj.clpt.6100223. PubMed: 17495877.
  46. 46. Bandmann O, Burton EA (2010) Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 40: 58-65. doi:10.1016/j.nbd.2010.05.017. PubMed: 20493258.